XRTX
Xortx Therapeutics
$2.02
−$0.01 (−0.25%)Jul 27, 2026
Key metrics
The numbers that frame XRTX today
- Market cap
- $2.81M
- P/E (TTM)
- -1.4
- EV / FCF
- -1.4
- ROIC
- -322.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.73
- 52wk High
- $7.05
Growth
Revenue and earnings trend for XRTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XRTX
Is Xortx Therapeutics a good buy?
No. Xortx Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Xortx Therapeutics is selling at a very high price.
What is the market capitalization of XRTX?
Xortx Therapeutics's market capitalization is $2.81M.
What is the P/E ratio for XRTX stock?
Xortx Therapeutics's current P/E ratio is -1.4.
What is the 52-week high for XRTX stock?
The 52-week high for Xortx Therapeutics is $7.05. The current close of $2.02 is 71.3% below that high.
What is the 52-week low for XRTX stock?
The 52-week low for Xortx Therapeutics is $1.73. The current close of $2.02 is 17.1% above that low.
Does XRTX stock pay dividends?
Xortx Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XRTX?
Xortx Therapeutics's Debt / Equity ratio is 0.01.